SAMHSA Office of Behavioral Health Equity Recovery Month



Webinar: SAMHSA Office of Behavioral Health Equity Recovery Month

Thursday, September 22, 2022 1:30 PM – 3:00 PM ET

The purpose of this webinar will be to discuss the need for behavioral health equity to ensure individuals living in marginalized communities have access to recovery, treatment, and support.

Join us as our presenter, Dr. Victoria Cargill, will discuss:

  • The impact of discrimination, racism, and racial trauma on marginalized individuals living with substance use disorder
  • The intersecting effects of the social determinants of health: poverty, under education, illiteracy, etc.
  • The literature in the types of effective/successful interventions or substance abuse for this population and by population group
  • The barriers to equitable substance use treatment, recovery, and support
  • The next steps forward


Attend Webinar


Please click the link below to join the webinar:

Webinar ID: 161 401 7737. Passcode: 393593

Or One tap mobile :
US: +16468287666,,1614017737#,,,,*393593# or +15512851373,,1614017737#,,,,*393593#

Or Telephone:
US: +1 646 828 7666 or +1 551 285 1373


Victoria Cargill, MD, MSCE
Assistant Commissioner, Baltimore City Health Department

Dr. Victoria Cargill is a Boston and Harvard University trained board-certified internal medicine and HIV physician, and former Assistant Commissioner of Health at the Baltimore City Health Department, overseeing the Ryan White program and Community Risk Reduction/Syringe Support Services. Prior to becoming an Assistant Commissioner, she served as a senior policy analyst and program director for 20 years at the National Institutes of Health (NIH) in both the Office of AIDS Research (OAR) and the Office of Research on Women’s Health (ORWH). At OAR, she was the Director of Minority Research and Clinical Studies, and Acting Director of HIV Therapeutics Research. At ORWH, she served as the Associate Director for Interdisciplinary Research, and grew the U3 program focused on stimulating research on understudied, underreported, and underrepresented women to over $3 million dollars. She has also served as the acting chair of the FDA Antiviral Advisory Committee, including chairing the hearings of the first two U.S.-approved HCV antivirals.

A former co-investigator at the Case Western AIDS Clinical Trials Unit and the creator of an AIDS education and prevention adolescent-focused program that reached over 100,000 teens in five Ohio cities, she has extensive public health and HIV prevention research experience. Currently the principal investigator of a HRSA-funded Ending the HIV Epidemic grant, and the author of over 150 scientific articles, research presentations, book chapters and popular press educational materials, she has been nationally recognized as one of America’s Top Doctors. Dr. Cargill continues to consider patients and communities as her best teachers.